Cargando…

Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa

BACKGROUND: Thanks to the scale up of malaria control interventions, the malaria burden in Senegal has decreased substantially to the point that the National Malaria Control Programme plans to achieve malaria elimination by 2030. To guide such efforts, measuring and monitoring parasite population ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wotodjo, Amélé Nyedzie, Oboh, Mary Aigbiremo, Doucoure, Souleymane, Diagne, Nafissatou, Diène-Sarr, Fatoumata, Niang, Makhtar, Trape, Jean-François, Sokhna, Cheikh, Amambua-Ngwa, Alfred, D’Alessandro, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478411/
https://www.ncbi.nlm.nih.gov/pubmed/37670357
http://dx.doi.org/10.1186/s12936-023-04694-0
_version_ 1785101343933857792
author Wotodjo, Amélé Nyedzie
Oboh, Mary Aigbiremo
Doucoure, Souleymane
Diagne, Nafissatou
Diène-Sarr, Fatoumata
Niang, Makhtar
Trape, Jean-François
Sokhna, Cheikh
Amambua-Ngwa, Alfred
D’Alessandro, Umberto
author_facet Wotodjo, Amélé Nyedzie
Oboh, Mary Aigbiremo
Doucoure, Souleymane
Diagne, Nafissatou
Diène-Sarr, Fatoumata
Niang, Makhtar
Trape, Jean-François
Sokhna, Cheikh
Amambua-Ngwa, Alfred
D’Alessandro, Umberto
author_sort Wotodjo, Amélé Nyedzie
collection PubMed
description BACKGROUND: Thanks to the scale up of malaria control interventions, the malaria burden in Senegal has decreased substantially to the point that the National Malaria Control Programme plans to achieve malaria elimination by 2030. To guide such efforts, measuring and monitoring parasite population evolution and anti-malarial drugs resistance is extremely important. Information on the prevalence of parasite mutations related to drug resistance can provide a first signal of emergence, introduction and selection that can help with refining drug interventions. The aim of this study was to analyse the prevalence of anti-malarial drug resistance-associated markers before and after the implementation of artemisinin-based combination therapy (ACT) from 2005 to 2014 in Dielmo, a model site for malaria intervention studies in Senegal. METHODS: Samples from both malaria patients and Plasmodium falciparum asymptomatic carriers were analysed with high resolution melting (HRM) technique to genotype P. falciparum chloroquine resistance transporter (Pfcrt) gene haplotypes and multidrug-resistant protein 1 (Pfmdr1) gene at codons N86 and Y184. RESULTS: Among the 539 samples analysed, 474, 486, and 511 were successfully genotyped for Pfmdr1 N86, Y184, and Pfcrt, respectively. The prevalence of drug resistance markers was high, particularly during the malaria upsurges. Following the scale-up in bed net distribution, only the mutant (86F-like) variant of Pfmdr1 86 was present while during the malaria upsurges the predominance of two types 86Y-86N (43%) and 86F-like (56%) were observed. Most infections (87%) carried the wild type Y-allele at Pfmdr1 184 during the period of nets scale-up while during the malaria upsurges only 16% of infections had wild type and 79% of infections had mixed (mutant/wild) type. The frequency of the mixed genotypes SVMNT-like_CVMNK and SVMNT-like_CVIET within Pfcrt gene was particularly low during bednet scale up. Their frequency increased significantly (P < 0.001) during the malaria upsurges. CONCLUSION: This data demonstrated the effect of multiple interventions on the dynamics of drug resistance-associated mutations in the main malaria parasite P. falciparum in an endemic village in Senegal. Monitoring drug resistance markers should be conducted periodically to detect threats of emergence or resurgence that could compromise the efficacy of anti-malarial drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-023-04694-0.
format Online
Article
Text
id pubmed-10478411
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104784112023-09-06 Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa Wotodjo, Amélé Nyedzie Oboh, Mary Aigbiremo Doucoure, Souleymane Diagne, Nafissatou Diène-Sarr, Fatoumata Niang, Makhtar Trape, Jean-François Sokhna, Cheikh Amambua-Ngwa, Alfred D’Alessandro, Umberto Malar J Research BACKGROUND: Thanks to the scale up of malaria control interventions, the malaria burden in Senegal has decreased substantially to the point that the National Malaria Control Programme plans to achieve malaria elimination by 2030. To guide such efforts, measuring and monitoring parasite population evolution and anti-malarial drugs resistance is extremely important. Information on the prevalence of parasite mutations related to drug resistance can provide a first signal of emergence, introduction and selection that can help with refining drug interventions. The aim of this study was to analyse the prevalence of anti-malarial drug resistance-associated markers before and after the implementation of artemisinin-based combination therapy (ACT) from 2005 to 2014 in Dielmo, a model site for malaria intervention studies in Senegal. METHODS: Samples from both malaria patients and Plasmodium falciparum asymptomatic carriers were analysed with high resolution melting (HRM) technique to genotype P. falciparum chloroquine resistance transporter (Pfcrt) gene haplotypes and multidrug-resistant protein 1 (Pfmdr1) gene at codons N86 and Y184. RESULTS: Among the 539 samples analysed, 474, 486, and 511 were successfully genotyped for Pfmdr1 N86, Y184, and Pfcrt, respectively. The prevalence of drug resistance markers was high, particularly during the malaria upsurges. Following the scale-up in bed net distribution, only the mutant (86F-like) variant of Pfmdr1 86 was present while during the malaria upsurges the predominance of two types 86Y-86N (43%) and 86F-like (56%) were observed. Most infections (87%) carried the wild type Y-allele at Pfmdr1 184 during the period of nets scale-up while during the malaria upsurges only 16% of infections had wild type and 79% of infections had mixed (mutant/wild) type. The frequency of the mixed genotypes SVMNT-like_CVMNK and SVMNT-like_CVIET within Pfcrt gene was particularly low during bednet scale up. Their frequency increased significantly (P < 0.001) during the malaria upsurges. CONCLUSION: This data demonstrated the effect of multiple interventions on the dynamics of drug resistance-associated mutations in the main malaria parasite P. falciparum in an endemic village in Senegal. Monitoring drug resistance markers should be conducted periodically to detect threats of emergence or resurgence that could compromise the efficacy of anti-malarial drugs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-023-04694-0. BioMed Central 2023-09-05 /pmc/articles/PMC10478411/ /pubmed/37670357 http://dx.doi.org/10.1186/s12936-023-04694-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wotodjo, Amélé Nyedzie
Oboh, Mary Aigbiremo
Doucoure, Souleymane
Diagne, Nafissatou
Diène-Sarr, Fatoumata
Niang, Makhtar
Trape, Jean-François
Sokhna, Cheikh
Amambua-Ngwa, Alfred
D’Alessandro, Umberto
Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title_full Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title_fullStr Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title_full_unstemmed Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title_short Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa
title_sort rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in dielmo village, senegal, west africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478411/
https://www.ncbi.nlm.nih.gov/pubmed/37670357
http://dx.doi.org/10.1186/s12936-023-04694-0
work_keys_str_mv AT wotodjoamelenyedzie reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT obohmaryaigbiremo reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT doucouresouleymane reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT diagnenafissatou reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT dienesarrfatoumata reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT niangmakhtar reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT trapejeanfrancois reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT sokhnacheikh reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT amambuangwaalfred reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica
AT dalessandroumberto reboundofmultipleinfectionsandprevalenceofantimalarialresistanceassociatedmarkersfollowingmalariaupsurgesindielmovillagesenegalwestafrica